Platelet activation by oxidized low density lipoprotein is mediated by Cd36 and scavenger receptor-A

被引:77
作者
Korporaal, Suzanne J. A.
Van Eck, Miranda
Adelmeijer, Jelle
Ijsseldijk, Martin
Out, Ruud
Lisman, Ton
Lenting, Peter J.
Van Berkel, Theo J. C.
Akkerman, Jan-Willem N.
机构
[1] Univ Utrecht, Med Ctr, Dept Clin Chem & Haematol G03 550, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht, Inst Biomembranes, NL-3508 TC Utrecht, Netherlands
[3] Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands
关键词
platelets; LDL; oxidized LDL; CD36; scavenger receptor-A;
D O I
10.1161/ATVBAHA.107.150698
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-The interaction of platelets with low density lipoprotein (LDL) contributes to the development of cardiovascular disease. Platelets are activated by native LDL (nLDL) through apoE Receptor 2' (apoER2')-mediated signaling to p38(MAPK) and by oxidized LDL (oxLDL) through lysophosphatidic acid (LPA) signaling to Rho A and Ca2+. Here we report a new mechanism for platelet activation by oxLDL. Methods and Results-Oxidation of nLDL increases p38MAPK activation through a mechanism that is (1) independent of LPA, and (2) unlike nLDL-signaling not desensitized by prolonged platelet-LDL contact or inhibited by receptorassociated protein or chondroitinase ABC. Antibodies against scavenger receptors CD36 and SR-A alone fail to block p38MAPK activation by oxLDL but combined blockade inhibits p38MAPK by > 40% and platelet adhesion to fibrinogen under flow by > 60%. Mouse platelets deficient in either CD36 or SR-A show normal p38MAPK activation by oxLDL but combined deficiency of CD36 and SR-A disrupts oxLDL-induced activation of p38MAPK by > 70%. Conclusion-These findings reveal a novel platelet-activating pathway stimulated by oxLDL that is initiated by the combined action of CD36 and SR-A.
引用
收藏
页码:2476 / 2483
页数:8
相关论文
共 37 条
  • [1] PLATELET ACTIVATION BY OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS
    ARDLIE, NG
    SELLEY, ML
    SIMONS, LA
    [J]. ATHEROSCLEROSIS, 1989, 76 (2-3) : 117 - 124
  • [2] Identification of the principal proteoglycan-binding site in LDL -: A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding
    Borén, J
    Olin, K
    Lee, I
    Chait, A
    Wight, TN
    Innerarity, TL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) : 2658 - 2664
  • [3] Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets - Relevance of the effect of oxidized LDL on platelet function
    Chen, LY
    Mehta, P
    Mehta, JL
    [J]. CIRCULATION, 1996, 93 (09) : 1740 - 1746
  • [4] Activation-dependent surface expression of LOX-1 in human platelets
    Chen, MY
    Kakutani, M
    Naruko, T
    Ueda, M
    Narumiya, S
    Masaki, T
    Sawamura, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (01) : 153 - 158
  • [5] How the protease thrombin talks to cells
    Coughlin, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 11023 - 11027
  • [6] PLATELET-ADHESION TO FIBRIN(OGEN)
    ENDENBURG, SC
    HANTGAN, RR
    SIXMA, JJ
    DEGROOT, PG
    ZWAGINGA, JJ
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (01) : 139 - 142
  • [7] THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL
    ESTERBAUER, H
    GEBICKI, J
    PUHL, H
    JURGENS, G
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) : 341 - 390
  • [8] ESTERBAUER H, 1987, J LIPID RES, V28, P495
  • [9] Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence
    Greaves, DR
    Gough, PJ
    Gordon, S
    [J]. CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (05) : 425 - 432
  • [10] Early platelet activation by low density lipoprotein via p38MAP kinase
    Hackeng, CM
    Relou, IAM
    Pladet, MW
    Gorter, G
    van Rijn, HJM
    Akkerman, JWN
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) : 1749 - 1756